Tarsus Pharmaceuticals Hits Day High with 7.33% Surge in Stock Price
Tarsus Pharmaceuticals, Inc. has shown strong stock performance, with significant gains over various time frames, including a 101.05% return over the past year. The company reported net sales of USD 102.66 million and increased stakeholder holdings, indicating rising confidence in its future prospects within the pharmaceuticals sector.
